Genetic Signatures Limited (GSS) Q4 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Genetic Signatures Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.153 Good morning, ladies and gentlemen, and welcome to this morning's 00:00:05.153 -- 00:00:10.194 webinar. My name is Maria Halas, and I am the CEO of 00:00:10.194 -- 00:00:12.495 Genetic Signatures. 00:00:12.495 -- 00:00:17.917 With me today is Angie Wang, who is our head of finance, 00:00:17.917 -- 00:00:21.278 and Angie is joining us for the first time. 00:00:21.278 -- 00:00:26.900 She has recently been promoted, and this is her first annual audit and financial 00:00:26.900 -- 00:00:31.989 results release. and the fact that she became quite ill recently right after 00:00:31.989 -- 00:00:35.970 we released the result has nothing to do with the stress that she may have been under 00:00:35.970 -- 00:00:39.631 during the course of the audit. 00:00:39.871 -- 00:00:45.273 With that in mind, I would like to just note the order for the day. 00:00:45.273 -- 00:00:50.454 The order will be that I'll make a short presentation on the actual results, 00:00:50.454 -- 00:00:54.715 following which we will open up for questions 00:00:54.715 -- 00:01:00.033 and you'll be able to ask. We have had some questions that have been submitted 00:01:00.033 -- 00:01:03.775 prior to the meeting and I will start 00:01:03.775 -- 00:01:08.317 by answering those questions and then open it for the forum. 00:01:08.317 -- 00:01:13.659 Obviously today's topic is the financial results for the 2026 00:01:13.659 -- 00:01:16.259 financial year. 00:01:19.762 -- 00:01:24.924 What we'll be talking about is really first I just want to recap on 00:01:24.924 -- 00:01:30.002 about genetic signatures and the Real advantages all around the company's assets, 00:01:30.002 -- 00:01:31.983 our product portfolio, 00:01:31.983 -- 00:01:37.267 and generally where we sit on the market. I w...